Differential expression of MUC1 and carbohydrate antigens in primary and secondary head and neck squamous cell carcinoma

Head and Neck

Volumn 30, Issue 5, 2008, Pages 647-657

  Croce, María V ^a,b   Rabassa, Martín E ^a,c   Pereyra, Adrián ^a   Segal Eiras, Amada ^a,b  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b CIC/PBA ^*

^c Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas

Author keywords

Carbohydrate antigens; HNSCC; Immunohistochemistry; MUC1; Tumor dissemination

Indexed keywords

CARBOHYDRATE ANTIGEN; LEWIS X ANTIGEN; LEWIS Y ANTIGEN; MUCIN 1; SIALYL LEWIS X ANTIGEN; SIALYL TN ANTIGEN; TN ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP LEWIS SYSTEM; CANCER PATIENT; CANCER RECURRENCE; CENTRIFUGATION; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NOSE CARCINOMA; PARANASAL SINUS CARCINOMA; PHARYNX CARCINOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE HOMOGENATE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BLOTTING, WESTERN; CA-15-3 ANTIGEN; CARCINOMA, SQUAMOUS CELL; EPITOPES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TUMOR MARKERS, BIOLOGICAL;

EID: 43249085965     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20756     Document Type: Article

References (30)

1. Dobrossy L. Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev 2005;24:9-17.
2. Kramer RH, Shen X, Zhou H. Tumor cell invasion and survival in head and neck cancer. Cancer Metastasis Rev 2005;24:35-45.
3. Duffy MJ, Shering S, Sherry F, McDermott E, O'Higgins N. CA 15-3: a prognostic marker in breast cancer. Int J Biol Markers 2000;15:330-333.
4. Gendler SJ. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia 2001;6:339-353.
5. Levitin F, Stern O, Weiss M, et al. The MUC1 SEA module is a self-cleaving domain. J Biol Chem 2005;280:33374-33386.
6. Gaemers IC, Vos HL, Volders HH, van der Valk SW, Hilkens J. A stat-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells. J Biol Chem 2001;276:6191-6199.
7. Bieche I, Lidereau R. A gene dosage effect is responsible for high overexpression of the MUC1 gene observed in human breast tumors. Cancer Genet Cytogenet 1997;98:75-80.
8. Rahn JJ, Dabbagh L, Pasdar M, Hugh JC. The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature. Cancer 2001;91:1973-1982.
9. Taylor-Papadimitriou J, Burchell J, Miles DW, Dalziel M. MUC1 and cancer. Biochim Biophys Acta 1999;1455:301-313.
10. Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 2004;95:377-384.
11. Julien S, Adriaenssens E, Ottenberg K, et al. ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumorigenicity. Glycobiology 2006;16:54-64.
12. Price MR, Edwards S, Owainati A, et al. Multiple epitopes on a human breast-carcinoma-associated antigen. Int J Cancer 1985;36:567-574.
13. Taylor-Papadimitriou J, Peterson JA, Arklie J, Burchell J, Ceriani RL, Bodmer WF. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer 1981;28:17-21.
14. Croce MV, Isla-Larrain M, Remes-Lenicov F, et al. MUC1 cytoplasmic tail detection using CT33 polyclonal and CT2 monoclonal antibodies in breast and colorectal tissue. Histol Histopathol 2006;21:849-855.
15. Hanai N, Shitara K, Yoshida H. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung. Cancer Res 1986;46:4438-4443.
16. Brown A, Feizi T, Gooi HC, Embleton MJ, Picard JK, Baldwin RW. A monoclonal antibody against human colonic adenoma recognizes difucosylated Type-2-blood-group chains. Biosci Rep 1983;3:163-170.
17. Croce MV, Isla-Larrain MT, Rua CE, Rabassa ME, Gendler SJ, Segal-Eiras A. Patterns of MUC1 tissue expression defined by an anti-MUC1 cytoplasmic tail monoclonal antibody in breast cancer. J Histochem Cytochem 2003;51:781-788.
18. Fernandez B, Lund J, Meyers F. Epithelial membrane antigen expression in benign and malignant squamous epithelium of the head and neck. Otolaryngol Head Neck Surg 1987;97:288-293.
19. Tatemoto Y, Saka M, Tanimura T, Mori M. Immunohistochemical observations on binding of monoclonal antibody to epithelial membrane antigen in epithelial tumors of the oral cavity and skin. Oral Surg Oral Med Oral Pathol 1987;64:721-726.
20. Jeannon JP, Aston V, Stafford FW, Soames JV, Wilson JA. Expression of MUC1 and MUC2 glycoproteins in laryngeal cancer. Clin Otolaryngol Allied Sci 2001;26:109-112.
21. Itoh T, Yonezawa S, Nomoto M, Ueno K, Kim YS, Sato E. Expression of mucin antigens and Lewis X-related antigens in carcinomas and dysplasia of the pharynx and larynx. Pathol Int 1996;46:646-655.
22. Nitta T, Sugihara K, Tsuyama S, Murata F. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis. Cancer 2000;88:245-254.
23. Sengupta A, Valdramidou D, Huntley S, Hicks SJ, Carrington SD, Corfield AP. Distribution of MUC1 in the normal human oral cavity is localized to the ducts of minor salivary glands. Arch Oral Biol 2001;46:529-538.
24. Spencer DI, Price MR, Tendler SJ, De Matteis CI, Stadie T, Hanisch FG. Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies. Cancer Lett 1996;100:11-15.
25. Croce MV, Isla-Larrain MT, Rua CE, Rabassa ME, Gendler SJ, Segal-Eiras A. Patterns of MUC1 tissue expression defined by an anti-MUC1 cytoplasmic tail monoclonal antibody in breast cancer. J Histochem Cytochem 2003;5:781-788.
26. Singh PK, Hollingsworth MA. Cell surface-associated mucins in signal transduction. Trends Cell Biol 2006;16:467-476.
27. Farmer RW, Richtsmeier WJ, Scher RL. Identification of sialyl Lewis-x in squamous cell carcinoma of the head and neck. Head Neck 1998;20:726-731.
28. Kurahara S, Shinohara M, Ikebe T, et al. Immunohistochemical study of sialyl Le(a) and sialyl Le(x) antigen in oral squamous cell carcinoma: the association of sialyl Le(a) expression with the metastatic potential. Head Neck 1999;21:330-337.
29. Jensen P, Clausen OP, Bryne M. Differences in sialyl-Tn antigen expression between keratoacanthomas and cutaneous squamous cell carcinomas. J Cutan Pathol 1999;26:183-189.
30. Croce MV, Price MR, Segal-Eiras A. Detection and isolation of MUC1 mucin from larynx squamous cell carcinoma. Pathol Oncol Res 2000;6:93-99.